Eli Lilly & Co
LLY· NYSE
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q4 2012 | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures | Q4 2009dderived from reported figures |
|---|---|---|---|---|
| Revenue | $5.96B | $6.05B | $6.19B | $5.93B |
| Net Income | $827.20M | $858.20M | $1.17B | $915.40M |
Eli Lilly & Co · CIK 59478 · Engraved from SEC EDGAR
| EPS Diluted | $0.74 | — | — | — |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.